GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accolade Inc (NAS:ACCD) » Definitions » Scaled Net Operating Assets

ACCD (Accolade) Scaled Net Operating Assets : 0.43 (As of Nov. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Accolade Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Accolade's operating assets for the quarter that ended in Nov. 2024 was $422.0 Mil. Accolade's operating liabilities for the quarter that ended in Nov. 2024 was $96.6 Mil. Accolade's Total Assets for the quarter that ended in Aug. 2024 was $756.1 Mil. Therefore, Accolade's scaled net operating assets (SNOA) for the quarter that ended in Nov. 2024 was 0.43.


Accolade Scaled Net Operating Assets Historical Data

The historical data trend for Accolade's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accolade Scaled Net Operating Assets Chart

Accolade Annual Data
Trend Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Scaled Net Operating Assets
Get a 7-Day Free Trial -4.09 -0.59 1.70 0.37 0.50

Accolade Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.57 0.57 0.56 0.43

Competitive Comparison of Accolade's Scaled Net Operating Assets

For the Health Information Services subindustry, Accolade's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accolade's Scaled Net Operating Assets Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Accolade's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Accolade's Scaled Net Operating Assets falls into.



Accolade Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Accolade's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Feb. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Feb. 2024 )
=(Operating Assets (A: Feb. 2024 )-Operating Liabilities (A: Feb. 2024 ))/Total Assets (A: Feb. 2023 )
=(551.118-101.038)/903.069
=0.50

where

Operating Assets(A: Feb. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=788.151 - 237.033
=551.118

Operating Liabilities(A: Feb. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=342.686 - 234.559 - 7.089
=101.038

Accolade's Scaled Net Operating Assets (SNOA) for the quarter that ended in Nov. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Nov. 2024 )
=(Operating Assets (Q: Nov. 2024 )-Operating Liabilities (Q: Nov. 2024 ))/Total Assets (Q: Aug. 2024 )
=(421.972-96.559)/756.072
=0.43

where

Operating Assets(Q: Nov. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=647.451 - 225.479
=421.972

Operating Liabilities(Q: Nov. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=334.451 - 230.551 - 7.341
=96.559

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accolade Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Accolade's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Accolade Business Description

Traded in Other Exchanges
Address
1201 Third Avenue, Suite 1700, Seattle, WA, USA, 98101
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
Executives
Stephen H. Barnes officer: Chief Financial Officer C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Rajeev Singh director, officer: Chief Executive Officer 6222 185TH AVENUE NE, REDMOND WA 98052
Robert N Cavanaugh officer: President 1601 CLOVERFIELD BLVD., SUITE 620, SANTA MONICA CA 90404
Richard Eskew officer: EVP General Counsel C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Mchugh Colin officer: Chief Accounting Officer C/O ACCOLADE, INC., 660 W. GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Michael W Hilton officer: Chief Product Officer 6222 185TH AVE, REDMOND WA 98052
Peter S Klein director C/O MICROSOFT CORPORATION, ONE MICROSOFT WAY, REDMOND WA 98052-6399
Cindy Kent director 7601 PENN AVENUE SOUTH, RICHFIELD MN 55418
Patricia L Wadors director C/O ALIGN TECHNOLOGY INC, 881 MARTIN AVE, SANTA CLARA CA 95050
Dawn G Lepore director 1425 BROADWAY PMB 41, SEATTLE WA 99122
Jeffrey D Jordan director 2865 SAND HILL ROAD #101, MENLO PARK CA 94025
Elizabeth G Nabel director BRIGHAM AND WOMEN'S HOSPITAL, 75 FRANCIS ST, BOSTON MA 02115
Jeffrey S Brodsky director C/O MORGAN STANLEY 1585 BROADWAY, NEW YORK NY 10036
Thomas J Neff director SPENCER STUART & ASSOCIATES, 277 PARK AVE, NEW YORK NY 10172
William H. Frist director 600 MONTGOMERY STREET, SAN FRANCISCO CA 94111